Use of COVID-19 Vaccines in the United States

Interim Clinical Considerations

Summary of recent changes (last updated June 24, 2022):
  • New guidance for use of Moderna COVID-19 Vaccine in children and adolescents ages 6–17 years
More about the Interim Clinical Considerations

See the FAQ page for answers to commonly asked questions about the Interim Clinical Considerations.

Page last reviewed: June 24, 2022